Larimar Therapeutics Earnings
NASDAQ: LRMRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.71+0.005 (+0.19%)
Market open · Delayed 15 min · as of Oct 9, 1:33 PM ET
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.35
Larimar Therapeutics earnings summary
Larimar Therapeutics is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-0.35.
Summary generated from market data by MetaCap's automated system. Methodology